Last reviewed · How we verify
Placebo 1 bag, three times a day
Placebo produces no pharmacological effect and serves as an inert control in clinical research.
Placebo produces no pharmacological effect and serves as an inert control in clinical research. Used for Clinical trial control arm (non-therapeutic use).
At a glance
| Generic name | Placebo 1 bag, three times a day |
|---|---|
| Sponsor | Qilu Hospital of Shandong University |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo is a non-active substance administered in clinical trials to establish baseline outcomes and control for the placebo effect—the therapeutic benefit arising from patient expectation rather than the drug's inherent properties. It allows researchers to isolate the true efficacy of an investigational treatment by comparing outcomes between placebo and active drug groups.
Approved indications
- Clinical trial control arm (non-therapeutic use)
Common side effects
Key clinical trials
- Characterization of Gut Microbiota Composition and Activity After a Daily Supplementation of 4.5 g/Day of ChitinGlucan Fibre During 3 Weeks in At-cardiometabolic Risk Volunteers (NA)
- Qishenyiqi Dripping Pill for Coronary Microvascular Disease (PHASE4)
- Qishenyiqi for Ventricular Remodeling After Myocardial Infarction (PHASE4)
- Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease (PHASE3)
- LA Improves the Prognosis of Patients With ICVD (NA)
- Efficacy and Safety of Zihua Wenfei Granules in Treatment of Postinfectious Cough (Wind-cold Invading Lungs Syndrome) (PHASE3)
- Clinical Trials of Five Different Food Supplements With Restriction Diet in Adults (NA)
- Oral Baidi Quzhi Granule Combined With Ju Ying Cream for Acne Vulgaris (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: